Common side effects include gastrointestinal symptoms (nausea, vomiting, diarrhoea)
Effect of glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors among obese/overweight individuals treated with antipsychotic drug classes: an updated systematic review and meta-analysis of randomized controlled trials
Omzo's published disclosures note it does not sell, dispense, or ship branded medications under its standard model - availability of branded options should be confirmed directly with Omzo prior to enrollment
Frequently Asked Questions Will You Need GLP-1 Medications Forever
Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials